Search Results - "Lagadinou, E.D."
-
1
-
2
Flavaglines target primitive leukemia cells and enhance anti-leukemia drug activity
Published in Leukemia (01-10-2014)“…Identification of agents that target human leukemia stem cells is an important consideration for the development of new therapies. The present study…”
Get full text
Journal Article -
3
c-Jun N-terminal kinase activation failure is a new mechanism of anthracycline resistance in acute myeloid leukemia
Published in Leukemia (01-10-2008)“…Chemotherapy resistance is a major challenge in acute myeloid leukemia (AML). Besides the P-glycoprotein efflux, additional cellular factors may contribute to…”
Get full text
Journal Article -
4
Human herpesvirus 6-related pure red cell aplasia, secondary graft failure, and clinical severe immune suppression after allogeneic hematopoietic cell transplantation successfully treated with foscarnet: HHV-6 and PRCA immune suppression after HCT
Published in Transplant infectious disease (01-10-2010)Get full text
Journal Article -
5
Human herpesvirus 6‐related pure red cell aplasia, secondary graft failure, and clinical severe immune suppression after allogeneic hematopoietic cell transplantation successfully treated with foscarnet
Published in Transplant infectious disease (01-10-2010)“…E.D. Lagadinou, M. Marangos, M. Liga, G. Panos, E. Tzouvara, E. Dimitroulia, M. Tiniakou, A. Tsakris, N. Zoumbos, A. Spyridonidis. Human herpesvirus 6‐related…”
Get full text
Journal Article -
6